Acquiring Company
Eli Lilly and Company
Acquired Company
Sigilon
Description
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Sigilon Therapeutics, Inc. (NASDAQ: SGTX). The acquisition allows Lilly to continue researching and developing encapsulated cell therapies, including SIG-002, for the treatment of type 1 diabetes.
Quick answer
Eli Lilly and Company is acquiring Sigilon, announced August 14, 2023. Eli Lilly and Company is based in Indianapolis, Indiana, United States.
- How much did Eli Lilly and Company pay for Sigilon?
- The deal value was not disclosed.
- What does Eli Lilly and Company do?
- Lilly is a medicine company turning science into healing to make life better for people around the world.
- Where are Eli Lilly and Company and Sigilon based?
- Eli Lilly and Company is based in Indianapolis, Indiana, United States.
- Who are the decision-makers at Eli Lilly and Company?
- Fundz holds 5 contacts at Eli Lilly and Company. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Theken Companies Acquires Visionair Solutions (August 22, 2023)
- Caldera Medical Acquires Atlantic Therapeutics To Expand Portfolio In Women’S Health (September 6, 2023)
- Cybin To Acquire Small Pharma Inc. (August 28, 2023)
- Lilly Completes Acquisition Of Dice Therapeutics (August 9, 2023)
- Lilly To Acquire Versanis To Improve Patient Outcomes In Cardiometabolic Diseases (July 14, 2023)
- Abbott Completes Acquisition Of Bigfoot Biomedical (September 22, 2023)
Who to call at Eli Lilly and Company, and when
When Eli Lilly and Company changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Eli Lilly and Company raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eli Lilly and Company, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eli Lilly and Company. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eli Lilly and Company makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Sigilon?
Sigilon was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on August 14, 2023. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is publicly traded (LLY) and operates in Manufacturing.
When did Eli Lilly and Company acquire Sigilon?
Eli Lilly and Company's acquisition of Sigilon was reported on August 14, 2023. Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Sigilon Therapeutics, Inc. (NASDAQ: SGTX). Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sigilon do?
Sigilon Therapeutics seeks to develop functional cures for patients with a broad range of acute and chronic diseases by harnessing the power of the human cell through its Shielded Living TherapeuticsTM platform. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.